Skip to main content

Genes and Money in Europe: Why Did It Fail?

  • Chapter
  • 184 Accesses

Abstract

This book is slightly unusual. Most business books are about how to run a successful business. This one aims to be a detailed, fact-based primer on how to fail in one of the world’s most exciting and fast-moving industrial sector — biotechnology.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Authors

Copyright information

© 2009 William Bains

About this chapter

Cite this chapter

Bains, W. (2009). Genes and Money in Europe: Why Did It Fail?. In: Venture Capital and the European Biotechnology Industry. Palgrave Macmillan, London. https://doi.org/10.1057/9780230227262_1

Download citation

Publish with us

Policies and ethics